Cleared Traditional

K904789 - SERIES 7000 CARBON DIOXIDE MODULE

K904789 is an FDA 510(k) clearance for SERIES 7000 CARBON DIOXIDE MODULE, manufactured by Marquette Electronics, Inc.. The device is a Class 2 Anesthesiology device with product code CCK cleared through the Traditional 510(k) pathway after a 211-day FDA review.

K904789 · Marquette Electronics, Inc. · Anesthesiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
May 1991
Decision
211d
Days
Class 2
Risk

K904789 is an FDA 510(k) clearance for the SERIES 7000 CARBON DIOXIDE MODULE. Classified as Analyzer, Gas, Carbon-dioxide, Gaseous-phase (product code CCK), Class II - Special Controls.

Submitted by Marquette Electronics, Inc. (Milwaukee, US). The FDA issued a Cleared decision on May 22, 1991 after a review of 211 days - an extended review cycle.

This device falls under the Anesthesiology FDA review panel, regulated under 21 CFR 868.1400 - the FDA anesthesiology and respiratory device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Anesthesiology review framework, consistent with the majority of Class II 510(k) submissions.

View all Marquette Electronics, Inc. devices

FDA 510(k) Submission Details - K904789

510(k) Number K904789 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received October 23, 1990
Decision Date May 22, 1991
Days to Decision 211 days
Submission Type Traditional
Review Panel Anesthesiology (AN)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
71d slower than avg
Panel avg: 140d · This submission: 211d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

CCK Device Classification - Class 2, Special Controls

Product Code CCK Analyzer, Gas, Carbon-dioxide, Gaseous-phase
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 868.1400
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Anesthesiology devices follow this clearance model.

Regulatory Peers - CCK Analyzer, Gas, Carbon-dioxide, Gaseous-phase

All 243
Devices cleared under the same product code (CCK) and FDA review panel - the closest regulatory comparables to K904789.
GAS SAMPLING INTERFACES
K914337 · Vital Signs, Inc. · Mar 1992
DISPOSABLE CO2 GAS SAMPLING/OXYGEN DELIVERY CANNUL
K915228 · Hospitak, Inc. · Feb 1992
OHMEDA MODEL 4700 OXICAP
K911193 · Ohmeda Medical · Aug 1991
PATIENT GAS SAMPLING LINE FOR OHMEDA 6000
K910509 · Intertech Resources, Inc. · Apr 1991
DATASCOPE MULTINEX ID MONITOR
K910106 · Datascope Corp. · Mar 1991
NOVAMETRIX MODEL 1265 END TIDAL CARBON DIOXIDE MON
K910019 · Novametrix Medical Systems, Inc. · Mar 1991